20M Germans Could Benefit From Medical Marijuana But Most Struggle To Find Prescribing Doctors
Frankfurt-based medical marijuana company Bloomwell Group Gmbh released a survey on cannabis consumption in Germany showing 94% of respondents use cannabis for at least one health reason. Stress relief was the most common reason (60%), followed by sleeping disorders (50.4%) and pain relief (35%).
“The responses illustrate the immense potential and room for growth of the country’s rapidly expanding medical cannabis industry following the implementation of the Cannabis Act (CanG) on April 1, 2024, which rescheduled cannabis as a non-narcotic,” stated Niklas Kouparanis, co-founder and CEO of the Bloomwell Group, the holding company for Bloomwell Gmbh. “According to the data from our survey, more than 20 million people in Germany could benefit from access to medical cannabis therapy.”
However, within the past year, only 10% of the survey participants obtained cannabis exclusively from licensed pharmacies while 79.6% reported negative experiences with the unlicensed market or safety concerns about unregulated products.
The survey comes after major cannabis reform in Germany with the implementation of the Cannabis Act (CanG). Partial cannabis legalization took effect in Germany on April 1 allowing people over 18 to legally possess up to 25 grams of dried cannabis and cultivate up to three plants at home. One of the biggest breakthroughs under the law is that medical cannabis is essentially regulated like ibuprofen.
Despite the reform, in practice, access to …